Janus Henderson Horizon Biotechnology Fund IU2 Acc EUR (Hedged)
WKN A3CSA7 | ISIN LU2342243362 | Fonds
Fonds
| ISIN | Name | Performance | Volatilität | Sharpe Ratio | ||
|---|---|---|---|---|---|---|
| 1 | CH0113817123 | Bellevue Biotech DT CHF | +4,81 % | +18,23 % | 0,13 |
|
| 2 | LU1269736838 | Candriam Equities L Biotech.R EUR Acc | -1,15 % | +18,18 % | -0,12 |
|
| 3 | LU1120766032 | Candriam Equities L Biotech.I EUR Acc | -1,39 % | +17,93 % | -0,13 |
|
| 4 | LU2026682919 | Candriam Equities L Biotech.V2 USD Acc | -0,91 % | +17,81 % | -0,19 |
|
| 5 | LU0942225912 | Candriam Equities L Biotech.R USD Acc | -1,13 % | +17,81 % | -0,16 |
|
| 51 | LU2342243362 | Janus Henderson Horizon Biotechnology Fund IU2 Acc EUR (Hedged) | -9,71 % | +23,11 % | -0,53 |
|
| 73 | LU0843168732 | Pictet - Biotech - HP CHF | -13,45 % | +23,12 % | -0,62 |
|
| 74 | LU1803069274 | F.Biotechnology Dis.Fd.A-H1 EUR H | -9,33 % | +18,97 % | -0,66 |
|
| 75 | LU0959058974 | Franklin Templeton Investment Funds Franklin Biotechnology Discovery Fund Klasse A (acc) CHF-H1 | -11,70 % | +19,03 % | -0,78 |
|
| 76 | DE000A3DCA95 | BIT Biotech Opportunities S | -33,02 % | +29,72 % | -1,20 |
|
| 77 | DE000A3DCBA0 | BIT Biotech Opportunities I-II | -33,18 % | +29,71 % | -1,20 |
|